Aurora Cannabis Inc. Common Shares

ACB

Aurora Cannabis Inc. is a Canadian company specializing in the production and sale of medical and recreational cannabis products. Established in 2006, it is one of the leading players in the global cannabis industry, with a large-scale cultivation and processing operation. Aurora focuses on innovative cannabis solutions, research, and development to serve both medicinal and adult-use markets worldwide.

$4.28 0.00 (0.00%)
Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
December 31, 2007$0.032007-12-192007-12-21
December 31, 2007$0.162007-12-192007-12-21
December 31, 2007$0.012007-12-192007-12-21

Dividends Summary

Company News

Do These 2 Cannabis Stocks Have a Future?
The Motley Fool • Prosper Junior Bakiny • December 29, 2025

President Trump's executive order rescheduling cannabis from Schedule 1 to Schedule 3 has improved the regulatory landscape for the cannabis industry, offering easier banking access and business expense deductions. However, analyst Prosper Junior Bakiny argues that Canopy Growth and Aurora Cannabis lack attractive investment prospects despite thi...

High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling
Benzinga • Erica Kollmann • December 17, 2025

President Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could potentially remove tax burdens on cannabis businesses and improve their financial prospects.

How Trump Has Fired Up Cannabis Stocks
Investing.com • Dave Kovaleski • September 29, 2025

Donald Trump's video on Truth Social praising hemp-derived CBD's health benefits triggered a significant surge in cannabis and CBD-related stocks, with some companies experiencing dramatic price increases.

$80 Bn Medical Marijuana Markets - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2032
GlobeNewswire Inc. • Researchandmarkets.Com • July 31, 2025

The global medical marijuana market is projected to grow from $30 billion in 2025 to $80 billion by 2032, driven by evolving regulations, increased healthcare acceptance, and therapeutic potential for managing conditions like chronic pain and mental health disorders.

Aurora Cannabis Inc. (ACB) Surpasses Q4 Earnings Estimates
Zacks Investment Research • Zacks Equity Research • June 20, 2024

Aurora Cannabis (ACB) delivered earnings and revenue surprises of 161.11% and 2.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related Companies